Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2
100 Clinical Results associated with Center For Chemistry Of Drugs
Login to view more data
0 Patents (Medical) associated with Center For Chemistry Of Drugs
Login to view more data
2
Literatures (Medical) associated with Center For Chemistry Of Drugs
01 Jan 1997·Drugs of the Future
Proxodolol
Author: Mashkovski, M. D. ; Yermakova, V. N. ; Yuzhakov, S. D. ; Sokolov, S. D. ; Vinogradova, S. M.
A review with 12 references on the synthesis and development of proxodolol as an antihypertensive and antianginal and antiglaucoma agent with β- and α-adrenoceptor antagonist activity in humans and laboratory animals.Proxodolol has been shown to an effective and well tolerated drug.
Drugs of the Future
Tetrindol: antidepressant cognition enhancer
Author: Glushkov, R. G. ; Mashkovsky, M. D. ; Andrejeva, N. I.
Tetrindol possesses properties typical for antidepressants as well as antiamnestic, antihypoxic, anticonvulsive and hypoanalgesic effects.Tetrindol behaves as a specific inhibitor of monoamine oxidase A and it is well tolerated.
100 Deals associated with Center For Chemistry Of Drugs
Login to view more data
100 Translational Medicine associated with Center For Chemistry Of Drugs
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.